{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:53:07Z","timestamp":1790358787306,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T00:00:00Z","timestamp":1556150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2015-41480-23972"],"award-info":[{"award-number":["2015-41480-23972"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2016-41480-25729"],"award-info":[{"award-number":["2016-41480-25729"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2017-41480-27310"],"award-info":[{"award-number":["2017-41480-27310"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["2018-41480-28805"],"award-info":[{"award-number":["2018-41480-28805"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00204-019-02464-z","type":"journal-article","created":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T15:06:23Z","timestamp":1556204783000},"page":"1865-1880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Integration of Food Animal Residue Avoidance Databank (FARAD) empirical methods for drug withdrawal interval determination with a mechanistic population-based interactive physiologically based pharmacokinetic (iPBPK) modeling platform: example for flunixin meglumine administration"],"prefix":"10.1007","volume":"93","author":[{"given":"Miao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsien","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason T.","family":"Chittenden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald E.","family":"Baynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Tell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Vickroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim E.","family":"Riviere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8731-8366","authenticated-orcid":false,"given":"Zhoumeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,25]]},"reference":[{"key":"2464_CR1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-1-4939-1289-6_15","volume-title":"Topical drug bioavailability, bioequivalence and penetration","author":"YG Anissimov","year":"2014","unstructured":"Anissimov YG, Roberts MS (2014) Mathematical models for topical and transdermal drug products. In: Shah VP, Maibach HI, Jenner J (eds) Topical drug bioavailability, bioequivalence and penetration, 2nd edn. Springer, New York, pp 249\u2013298","edition":"2"},{"key":"2464_CR2","unstructured":"Baron KT, Hindmarsh AC, Petzold LR, Gillespie B, Margossian C, Metrum Research Group LLC (2018) mrgsolve: simulation from ODE-based population PK\/PD and systems pharmacology models. R package version 0.8.12. https:\/\/metrumrg.com\/try-open-source-tools\/ . Accessed 14 Nov 2018"},{"key":"2464_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/9781118872819","volume-title":"Strategies for reducing drug and chemical residues in food animals: international approaches to residue avoidance, management, and testing","author":"R Baynes","year":"2014","unstructured":"Baynes R, Riviere JE (2014) Strategies for reducing drug and chemical residues in food animals: international approaches to residue avoidance, management, and testing. Wiley, Hoboken"},{"issue":"3","key":"2464_CR4","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1742-7843.2009.00488.x","volume":"106","author":"FY Bois","year":"2010","unstructured":"Bois FY (2010) Physiologically based modelling and prediction of drug interactions. Basic Clin Pharmacol Toxicol 106(3):154\u2013161","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"2464_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/jvp.12473","volume":"41","author":"C Bon","year":"2018","unstructured":"Bon C, Toutain PL, Concordet D, Gehring R, Martin-Jimenez T, Smith J, Pelligand L, Martinez M, Whittem T, Riviere JE, Mochel JP (2018) Mathematical modeling and simulation in animal health. Part III: using nonlinear mixed-effects to characterize and quantify variability in drug pharmacokinetics. J Vet Pharmacol Ther 41(2):171\u2013183","journal-title":"J Vet Pharmacol Ther"},{"issue":"4","key":"2464_CR6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1177\/074823379701300401","volume":"13","author":"RP Brown","year":"1997","unstructured":"Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP (1997) Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13(4):407\u2013484","journal-title":"Toxicol Ind Health"},{"issue":"10","key":"2464_CR7","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.2460\/ajvr.2005.66.1686","volume":"66","author":"JL Buur","year":"2005","unstructured":"Buur JL, Baynes RE, Craigmill AL, Riviere JE (2005) Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues. Am J Vet Res 66(10):1686\u20131693","journal-title":"Am J Vet Res"},{"issue":"5","key":"2464_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1365-2885.2006.00788.x","volume":"29","author":"JL Buur","year":"2006","unstructured":"Buur JL, Baynes RE, Smith GW, Riviere JE (2006a) Pharmacokinetics of flunixin meglumine in swine after intravenous dosing. J Vet Pharmacol Ther 29(5):437\u2013440","journal-title":"J Vet Pharmacol Ther"},{"issue":"7","key":"2464_CR9","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1128\/AAC.01355-05","volume":"50","author":"JL Buur","year":"2006","unstructured":"Buur JL, Baynes RE, Smith GW, Riviere JE (2006b) Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine. Antimicrob Agents Chemother 50(7):2344\u20132351","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2464_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v076.i01","volume":"76","author":"B Carpenter","year":"2017","unstructured":"Carpenter B, Gelman A, Hoffman M, Lee D, Goodrich B, Betancourt M, Brubaker M, Guo J, Li P, Riddell A (2017) Stan: a probabilistic programming language. J Stat Softw 76(1):1\u201332","journal-title":"J Stat Softw"},{"issue":"6","key":"2464_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s10646-016-1672-4","volume":"25","author":"Y-H Cheng","year":"2016","unstructured":"Cheng Y-H, Lin Y-J, You S-H, Yang Y-F, How C-M, Tseng Y-T, Chen W-Y, Liao C-M (2016) Assessing exposure risks for freshwater tilapia species posed by mercury and methylmercury. Ecotoxicology 25(6):1181\u20131193","journal-title":"Ecotoxicology"},{"issue":"7","key":"2464_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/bdd.2018","volume":"37","author":"JT Chittenden","year":"2016","unstructured":"Chittenden JT, Riviere JE (2016) Assessment of penetrant and vehicle mixture properties on transdermal permeability using a mixed effect pharmacokinetic model of ex vivo porcine skin. Biopharm Drug Dispos 37(7):387\u2013396","journal-title":"Biopharm Drug Dispos"},{"key":"2464_CR13","doi-asserted-by":"crossref","unstructured":"Chou WC, Lin Z (2019) Bayesian evaluation of a physiologically based pharmacokinetic (PBPK) model for perfluorooctane sulfonate (PFOS) to characterize the interspecies uncertainty between mice, rats, monkeys, and humans: development and performance verification. Environ Int (in press)","DOI":"10.1016\/j.envint.2019.03.058"},{"key":"2464_CR14","doi-asserted-by":"publisher","first-page":"129e143","DOI":"10.1016\/j.yrtph.2007.10.012","volume":"50","author":"RA Clewell","year":"2008","unstructured":"Clewell RA, Clewell HJ (2008) Development and specification of physiologically based pharmacokinetic models for use in risk assessment. Regul Toxicol Pharmacol 50:129e143","journal-title":"Regul Toxicol Pharmacol"},{"issue":"6","key":"2464_CR15","doi-asserted-by":"publisher","first-page":"A333","DOI":"10.1289\/ehp.021100333","volume":"110","author":"RA Clewell","year":"2002","unstructured":"Clewell RA, Gearhart JM (2002) Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure. Environ Health Perspect 110(6):A333\u2013A337","journal-title":"Environ Health Perspect"},{"key":"2464_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41370-018-0046-9","volume":"29","author":"EA Cohen Hubal","year":"2018","unstructured":"Cohen Hubal EA, Wetmore BA, Wambaugh JF, El-Masri H, Sobus JR, Bahadori T (2018) Advancing internal exposure and physiologically-based toxicokinetic modeling for 21st-century risk assessments. J Expo Sci Environ Epidemiol 29:11\u201320","journal-title":"J Expo Sci Environ Epidemiol"},{"issue":"1","key":"2464_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yrtph.2006.06.008","volume":"47","author":"TR Covington","year":"2007","unstructured":"Covington TR, Robinan Gentry P, Van Landingham CB, Andersen ME, Kester JE, Clewell HJ (2007) The use of Markov chain Monte Carlo uncertainty analysis to support a Public Health Goal for perchloroethylene. Regul Toxicol Pharmacol 47(1):1\u201318","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"2464_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1046\/j.1365-2885.2003.00451.x","volume":"26","author":"A Craigmill","year":"2003","unstructured":"Craigmill A (2003) A physiologically based pharmacokinetic model for oxytetracycline residues in sheep. J Vet Pharmacol Ther 26(1):55\u201363","journal-title":"J Vet Pharmacol Ther"},{"key":"2464_CR19","volume-title":"Tabulation of FARAD comparative and veterinary pharmacokinetic data","author":"AL Craigmill","year":"2006","unstructured":"Craigmill AL, Riviere JE, Webb AI (2006) Tabulation of FARAD comparative and veterinary pharmacokinetic data. Blackwell Pub, Ames"},{"issue":"10","key":"2464_CR20","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2165\/00003088-200645100-00005","volume":"45","author":"AN Edginton","year":"2006","unstructured":"Edginton AN, Schmitt W, Willmann S (2006) Development and evaluation of a generic physiologically based pharmacokinetic model for children. Clin Pharmacokinet 45(10):1013\u20131034","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"2464_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/toxsci\/kfw082","volume":"152","author":"H El-Masri","year":"2016","unstructured":"El-Masri H, Kleinstreuer N, Hines RN, Adams L, Tal T, Isaacs K, Wetmore BA, Tan YM (2016) Integration of life-stage physiologically based pharmacokinetic models with adverse outcome pathways and environmental exposure models to screen for environmental hazards. Toxicol Sci 152(1):230\u2013243","journal-title":"Toxicol Sci"},{"issue":"5","key":"2464_CR22","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/jvp.12676","volume":"41","author":"T Elwell-Cuddy","year":"2018","unstructured":"Elwell-Cuddy T, Li M, KuKanich B, Lin Z (2018) The construction and application of a population physiologically based pharmacokinetic model for methadone in Beagles and Greyhounds. J Vet Pharmacol Ther 41(5):670\u2013683","journal-title":"J Vet Pharmacol Ther"},{"key":"2464_CR23","unstructured":"EMEA (1999) Committee for veterinary medicinal products flunixin summary reports (1). http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Maximum_Residue_Limits_-_Report\/2009\/11\/WC500014324.pdf . Accessed 14 Nov 2018"},{"key":"2464_CR24","unstructured":"EPA (2006) Approaches for the application of physiologically based pharmacokinetic (PBPK) models and supporting data in risk assessment. Final Report EPA\/600\/R-05\/043A, Washington, DC, USA, 2006. http:\/\/ofmpub.epa.gov\/eims\/eimscomm.getfile?p_download_id=458188 . Accessed 25 Feb 2019"},{"key":"2464_CR25","unstructured":"FDA (1998) Freedom of information. NADA 101-479. BANAMINE (flunixin meglumine) Injectable Solution. US Food and Drug Administration, Silver Spring, MD. https:\/\/wayback.archive-it.org\/7993\/20170406083138\/https:\/\/www.fda.gov\/downloads\/AnimalVeterinary\/Products\/ApprovedAnimalDrugProducts\/FOIADrugSummaries\/ucm064905.pdf . Accessed 14 Nov 2018"},{"key":"2464_CR26","unstructured":"FDA (2005) Freedom of information. NADA 101-479. BANAMINE-S (flunixin meglumine) Injectable Solution. U.S. Food and Drug Administration, Silver Spring, MD. https:\/\/animaldrugsatfda.fda.gov\/adafda\/app\/search\/public\/document\/downloadFoi\/356 . Accessed 14 Nov 2018"},{"key":"2464_CR27","unstructured":"FDA (2012) Regulation of carcinogenic compounds used in food-producing animals. Code of federal regulations title 21, Parts 500.82. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=500.82 . Accessed 14 Nov 2018"},{"key":"2464_CR28","unstructured":"FDA (2018) Physiologically based pharmacokinetic analyses\u2014format and content. Guidance for Industry. https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM531207.pdf . Accessed 25 Feb 2019"},{"issue":"4","key":"2464_CR29","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/jvp.12370","volume":"40","author":"J Henri","year":"2017","unstructured":"Henri J, Carrez R, Meda B, Laurentie M, Sanders P (2017) A physiologically based pharmacokinetic model for chickens exposed to feed supplemented with monensin during their lifetime. J Vet Pharmacol Ther 40(4):370\u2013382","journal-title":"J Vet Pharmacol Ther"},{"issue":"2","key":"2464_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2885.2004.00551.x","volume":"27","author":"Y Horii","year":"2004","unstructured":"Horii Y, Ikenaga M, Shimoda M, Kokue E (2004) Pharmacokinetics of flunixin in the cat: enterohepatic circulation and active transport mechanism in the liver. J Vet Pharmacol Ther 27(2):65\u201369","journal-title":"J Vet Pharmacol Ther"},{"issue":"6","key":"2464_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/jvp.12128","volume":"37","author":"JT Howard","year":"2014","unstructured":"Howard JT, Baynes RE, Brooks JD, Yeatts JL, Bellis B, Ashwell MS, Routh P, O\u2019Nan AT, Maltecca C (2014) The effect of breed and sex on sulfamethazine, enrofloxacin, fenbendazole and flunixin meglumine pharmacokinetic parameters in swine. J Vet Pharmacol Ther 37(6):531\u2013541","journal-title":"J Vet Pharmacol Ther"},{"key":"2464_CR32","doi-asserted-by":"publisher","first-page":"588","DOI":"10.3389\/fphar.2018.00588","volume":"9","author":"NH Hsieh","year":"2018","unstructured":"Hsieh NH, Reisfeld B, Bois FY, Chiu WA (2018) Applying a global sensitivity analysis workflow to improve the computational efficiencies in physiologically-based pharmacokinetic modeling. Front Pharmacol 9:588","journal-title":"Front Pharmacol"},{"issue":"3","key":"2464_CR33","first-page":"199","volume":"11","author":"J Jaroszewski","year":"2008","unstructured":"Jaroszewski J, Jedziniak P, Markiewicz W, Grabowski T, Chrostowska M, Szprengier-Juszkiewicz T (2008) Pharmacokinetics of flunixin in mature heifers following multiple intravenous administration. Pol J Vet Sci 11(3):199\u2013203","journal-title":"Pol J Vet Sci"},{"issue":"3","key":"2464_CR34","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00204-017-2116-5","volume":"92","author":"SJ Kim","year":"2018","unstructured":"Kim SJ, Shin H, Lee YB, Cho HY (2018) Sex-specific risk assessment of PFHxS using a physiologically based pharmacokinetic model. Arch Toxicol 92(3):1113\u20131131","journal-title":"Arch Toxicol"},{"issue":"12","key":"2464_CR35","doi-asserted-by":"publisher","first-page":"7151","DOI":"10.3168\/jds.2012-5754","volume":"95","author":"LW Kissell","year":"2012","unstructured":"Kissell LW, Smith GW, Leavens TL, Baynes RE, Wu H, Riviere JE (2012) Plasma pharmacokinetics and milk residues of flunixin and 5-hydroxy flunixin following different routes of administration in dairy cattle. J Dairy Sci 95(12):7151\u20137157","journal-title":"J Dairy Sci"},{"issue":"6","key":"2464_CR36","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2460\/ajvr.77.6.634","volume":"77","author":"LW Kissell","year":"2016","unstructured":"Kissell LW, Brinson PD, Gehring R, Tell LA, Wetzlich SE, Baynes RE, Smith GW (2016) Pharmacokinetics and tissue elimination of flunixin in veal calves. Am J Vet Res 77(6):634\u2013640","journal-title":"Am J Vet Res"},{"issue":"6","key":"2464_CR37","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/jvp.12314","volume":"39","author":"MD Kleinhenz","year":"2016","unstructured":"Kleinhenz MD, Van Engen NK, Gorden PJ, KuKanich B, Rajewski SM, Walsh P, Coetzee JF (2016) The pharmacokinetics of transdermal flunixin meglumine in Holstein calves. J Vet Pharmacol Ther 39(6):612\u2013615","journal-title":"J Vet Pharmacol Ther"},{"issue":"3\u20134","key":"2464_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1751-0147-44-153","volume":"44","author":"K Konigsson","year":"2003","unstructured":"Konigsson K, Torneke K, Engeland IV, Odensvik K, Kindahl H (2003) Pharmacokinetics and pharmacodynamic effects of flunixin after intravenous, intramuscular and oral administration to dairy goats. Acta Vet Scand 44(3\u20134):153\u2013159","journal-title":"Acta Vet Scand"},{"issue":"10","key":"2464_CR39","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.2460\/javma.2005.227.1574","volume":"227","author":"B KuKanich","year":"2005","unstructured":"KuKanich B, Gehring R, Webb AI, Craigmill AL, Riviere JE (2005) Effect of formulation and route of administration on tissue residues and withdrawal times. J Am Vet Med Assoc 227(10):1574\u20131577","journal-title":"J Am Vet Med Assoc"},{"issue":"9","key":"2464_CR40","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1080\/19440049.2014.938363","volume":"31","author":"TL Leavens","year":"2014","unstructured":"Leavens TL, Tell LA, Kissell LW, Smith GW, Smith DJ, Wagner SA, Shelver WL, Wu H, Baynes RE, Riviere JE (2014) Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus). Food Addit Contam Part A Chem Anal Control Expo Risk Assess 31(9):1506\u20131521","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"issue":"4","key":"2464_CR41","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/jps.24341","volume":"104","author":"M Li","year":"2015","unstructured":"Li M, Gehring R, Lin Z, Riviere J (2015a) A framework for meta-analysis of veterinary drug pharmacokinetic data using mixed effect modeling. J Pharm Sci 104(4):1230\u20131239","journal-title":"J Pharm Sci"},{"issue":"6","key":"2464_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/psp4.39","volume":"4","author":"R Li","year":"2015","unstructured":"Li R, Barton HA, Maurer TS (2015b) A mechanistic pharmacokinetic model for liver transporter substrates under liver cirrhosis conditions. CPT Pharmacomet Syst Pharmacol 4(6):338\u2013349","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"key":"2464_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.fct.2017.06.023","volume":"107","author":"M Li","year":"2017","unstructured":"Li M, Gehring R, Riviere JE, Lin Z (2017) Development and application of a population physiologically based pharmacokinetic model for penicillin G in swine and cattle for food safety assessment. Food Chem Toxicol 107:74\u201387","journal-title":"Food Chem Toxicol"},{"issue":"1","key":"2464_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/toxsci\/kfy067","volume":"164","author":"M Li","year":"2018","unstructured":"Li M, Gehring R, Riviere JE, Lin Z (2018) Probabilistic physiologically based pharmacokinetic model for penicillin G in milk from dairy cows following intramammary or intramuscular administrations. Toxicol Sci 164(1):85\u2013100","journal-title":"Toxicol Sci"},{"issue":"1","key":"2464_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.taap.2010.11.009","volume":"251","author":"Z Lin","year":"2011","unstructured":"Lin Z, Fisher JW, Ross MK, Filipov NM (2011) A physiologically based pharmacokinetic model for atrazine and its main metabolites in the adult male C57BL\/6 mouse. Toxicol Appl Pharmacol 251(1):16\u201331","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"2464_CR46","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/jps.24244","volume":"104","author":"Z Lin","year":"2015","unstructured":"Lin Z, Li M, Gehring R, Riviere JE (2015) Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans. J Pharm Sci 104(1):233\u2013243","journal-title":"J Pharm Sci"},{"issue":"5","key":"2464_CR47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/jvp.12311","volume":"39","author":"Z Lin","year":"2016","unstructured":"Lin Z, Gehring R, Mochel JP, Lave T, Riviere JE (2016a) Mathematical modeling and simulation in animal health\u2014part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment. J Vet Pharmacol Ther 39(5):421\u2013438","journal-title":"J Vet Pharmacol Ther"},{"key":"2464_CR48","doi-asserted-by":"publisher","first-page":"27907","DOI":"10.1038\/srep27907","volume":"6","author":"Z Lin","year":"2016","unstructured":"Lin Z, Vahl CI, Riviere JE (2016b) Human food safety implications of variation in food animal drug metabolism. Sci Rep 6:27907","journal-title":"Sci Rep"},{"issue":"1","key":"2464_CR49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/toxsci\/kfx070","volume":"158","author":"Z Lin","year":"2017","unstructured":"Lin Z, Jaberi-Douraki M, He C, Jin S, Yang RS, Fisher JW, Riviere JE (2017) Performance assessment and translation of physiologically based pharmacokinetic models from acslX to Berkeley Madonna, MATLAB, and R language: oxytetracycline and gold nanoparticles as case examples. Toxicol Sci 158(1):23\u201335","journal-title":"Toxicol Sci"},{"issue":"2","key":"2464_CR50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3109\/03602532.2016.1157600","volume":"48","author":"MY Malik","year":"2016","unstructured":"Malik MY, Jaiswal S, Sharma A, Shukla M, Lal J (2016) Role of enterohepatic recirculation in drug disposition: cooperation and complications. Drug Metab Rev 48(2):281\u2013327","journal-title":"Drug Metab Rev"},{"issue":"3","key":"2464_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1046\/j.1365-2885.1998.00121.x","volume":"21","author":"T Martin-Jimenez","year":"1998","unstructured":"Martin-Jimenez T, Riviere JE (1998) Population pharmacokinetics in veterinary medicine: potential use for therapeutic drug monitoring and prediction of tissue residues. J Vet Pharmacol Ther 21(3):167\u2013189","journal-title":"J Vet Pharmacol Ther"},{"key":"2464_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fphar.2011.00031","volume":"2","author":"K McNally","year":"2011","unstructured":"McNally K, Cotton R, Loizou GD (2011) A workflow for global sensitivity analysis of PBPK models. Front Pharmacol 2:31","journal-title":"Front Pharmacol"},{"key":"2464_CR53","volume-title":"Drug Residues and microbial contamination in food: monitoring and enforcement","author":"NRC","year":"1999","unstructured":"NRC (1999a) Drug Residues and microbial contamination in food: monitoring and enforcement. National Academy Press, Washington, DC"},{"key":"2464_CR54","first-page":"110","volume-title":"The use of drugs in food animals: benefits and risks","author":"NRC","year":"1999","unstructured":"NRC (1999b) The use of drugs in food animals. In: Council NR (ed) The use of drugs in food animals: benefits and risks. National Academy Press, Washington, DC, pp 110\u2013141"},{"issue":"4","key":"2464_CR55","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1365-2885.1995.tb00589.x","volume":"18","author":"K Odensvik","year":"1995","unstructured":"Odensvik K (1995) Pharmacokinetics of flunixin and its effect on prostaglandin F2 alpha metabolite concentrations after oral and intravenous administration in heifers. J Vet Pharmacol Ther 18(4):254\u2013259","journal-title":"J Vet Pharmacol Ther"},{"issue":"4","key":"2464_CR56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2460\/ajvr.1995.56.04.489","volume":"56","author":"K Odensvik","year":"1995","unstructured":"Odensvik K, Johansson IM (1995) High-performance liquid chromatography method for determination of flunixin in bovine plasma and pharmacokinetics after single and repeated doses of the drug. Am J Vet Res 56(4):489\u2013495","journal-title":"Am J Vet Res"},{"key":"2464_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.yrtph.2017.08.019","volume":"90","author":"A Paini","year":"2017","unstructured":"Paini A, Leonard JA, Kliment T, Tan YM, Worth A (2017) Investigating the state of physiologically based kinetic modelling practices and challenges associated with gaining regulatory acceptance of model applications. Regul Toxicol Pharmacol 90:104\u2013115","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"2464_CR58","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/1746-6148-9-165","volume":"9","author":"MD Pairis-Garcia","year":"2013","unstructured":"Pairis-Garcia MD, Karriker LA, Johnson AK, Kukanich B, Wulf L, Sander S, Stalder KJ, Coetzee JF (2013) Pharmacokinetics of flunixin meglumine in mature swine after intravenous, intramuscular and oral administration. BMC Vet Res 9(1):165","journal-title":"BMC Vet Res"},{"issue":"4","key":"2464_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v079.i04","volume":"79","author":"RG Pearce","year":"2017","unstructured":"Pearce RG, Setzer RW, Strope CL, Wambaugh JF, Sipes NS (2017) Httk: R package for high-throughput toxicokinetics. J Stat Softw 79(4):1","journal-title":"J Stat Softw"},{"key":"2464_CR60","unstructured":"Pujol G, Iooss B, Boumhaout AJ with contributions from Veiga SD, Delage T, Fruth J, et al (2017) Sensitivity: global sensitivity analysis of model outputs. https:\/\/cran.r-project.org\/web\/packages\/sensitivity\/index.html . Accessed 4 Feb 2019"},{"issue":"9","key":"2464_CR61","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s40262-015-0253-7","volume":"54","author":"MF Rasool","year":"2015","unstructured":"Rasool MF, Khalil F, L\u00e4er S (2015) A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows. Clin Pharmacokinet 54(9):943\u2013962","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"2464_CR62","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.2460\/javma.250.10.1131","volume":"250","author":"JE Riviere","year":"2017","unstructured":"Riviere JE, Tell LA, Baynes RE, Vickroy TW, Gehring R (2017) Guide to FARAD resources: historical and future perspectives. J Am Vet Med Assoc 250(10):1131\u20131139","journal-title":"J Am Vet Med Assoc"},{"key":"2464_CR63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-pharmtox-010510-100540","volume":"51","author":"M Rowland","year":"2011","unstructured":"Rowland M, Peck C, Tucker G (2011) Physiologically-based pharmacokinetics in drug development and regulatory science. Annu Rev Pharmacol Toxicol 51:45\u201373","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"12","key":"2464_CR64","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s40262-016-0422-3","volume":"55","author":"JF Schlender","year":"2016","unstructured":"Schlender JF, Meyer M, Thelen K, Krauss M, Willmann S, Eissing T, Jaehde U (2016) Development of a whole-body physiologically based pharmacokinetic approach to assess the pharmacokinetics of drugs in elderly individuals. Clin Pharmacokinet 55(12):1573\u20131589","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"2464_CR65","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cpt.1013","volume":"104","author":"M Shebley","year":"2018","unstructured":"Shebley M, Sandhu P, Emami Riedmaier A et al (2018) Physiologically based pharmacokinetic model qualification and reporting procedures for regulatory submissions: a consortium perspective. Clin Pharmacol Ther 104(1):88\u2013110","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"2464_CR66","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1021\/jf304773p","volume":"61","author":"WL Shelver","year":"2013","unstructured":"Shelver WL, Tell LA, Wagner S, Wetzlich SE, Baynes RE, Riviere JE, Smith DJ (2013) Comparison of ELISA and LC\u2013MS\/MS for the measurement of flunixin plasma concentrations in beef cattle after intravenous and subcutaneous administration. J Agric Food Chem 61(11):2679\u20132686","journal-title":"J Agric Food Chem"},{"issue":"2","key":"2464_CR67","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2460\/javma.250.2.182","volume":"250","author":"PK Sidhu","year":"2017","unstructured":"Sidhu PK, Gehring R, Mzyk DA, Marmulak T, Tell LA, Baynes RE, Vickroy TW, Riviere JE (2017) Avoiding violative flunixin meglumine residues in cattle and swine. J Am Vet Med Assoc 250(2):182\u2013189","journal-title":"J Am Vet Med Assoc"},{"key":"2464_CR68","unstructured":"Skidmore A, Roder J, Van De Ven J, Cloet P, Montgomery A (2008) Flunixin meglumine (Finadyne\u00ae, Banamine\u00ae) in pain management of cattle: pharmacology and applications, proceedings XXV World Buiatrics Congress, July 6\u201311, 2008, Budapest, Hungary, p 293"},{"key":"2464_CR69","first-page":"5","volume-title":"Human health risks associated with drug residues in animal-derived foods veterinary drug residues","author":"SF Sundlof","year":"1996","unstructured":"Sundlof SF, Cooper J (1996) Human health risks associated with drug residues in animal-derived foods veterinary drug residues, vol 636. American Chemical Society, Washington, pp 5\u201317"},{"issue":"18","key":"2464_CR70","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1080\/15287390600631367","volume":"69","author":"YM Tan","year":"2006","unstructured":"Tan YM, Liao KH, Conolly RB, Blount BC, Mason AM, Clewell HJ (2006) Use of a physiologically based pharmacokinetic model to identify exposures consistent with human biomonitoring data for chloroform. J Toxicol Environ Health Part A 69(18):1727\u20131756","journal-title":"J Toxicol Environ Health Part A"},{"issue":"2","key":"2464_CR72","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/toxsci\/kfy010","volume":"162","author":"YM Tan","year":"2018","unstructured":"Tan YM, Worley RR, Leonard JA, Fisher JW (2018) Challenges associated with applying physiologically based pharmacokinetic modeling for public health decision-making. Toxicol Sci 162(2):341\u2013348","journal-title":"Toxicol Sci"},{"issue":"3","key":"2464_CR71","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/cpt.1205","volume":"105","author":"ML Tan","year":"2019","unstructured":"Tan ML, Zhao P, Zhang L, Ho YF, Varma MVS, Neuhoff S, Nolin TD, Galetin A, Huang SM (2019) Use of physiologically-based pharmacokinetic (PBPK) modeling to evaluate the effect of chronic kidney disease on the disposition of hepatic CYP2C8 and OATP1B drug substrates. Clin Pharmacol Ther 105(3):719\u2013729","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2464_CR73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1208\/s12248-018-0187-8","volume":"20","author":"IE Templeton","year":"2018","unstructured":"Templeton IE, Jones NS, Musib L (2018) Pediatric dose selection and utility of PBPK in determining dose. AAPS J 20(2):31","journal-title":"AAPS J"},{"key":"2464_CR74","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.rvsc.2017.04.010","volume":"114","author":"J Thiry","year":"2017","unstructured":"Thiry J, Fournier R, Roy O, Catala M (2017) Evaluation of flunixin meglumine pour-on administration on prostaglandin E2 concentration in inflammatory exudate after induction of inflammation in cattle. Res Vet Sci 114:294\u2013296","journal-title":"Res Vet Sci"},{"key":"2464_CR75","unstructured":"USDA (2018) US National Residue Program: residue sample results\u2014\"Red Book\u201d. https:\/\/www.fsis.usda.gov\/wps\/portal\/fsis\/topics\/data-collection-and-reports\/chemistry\/red-books\/red-book . Accessed 14 Nov 2018"},{"issue":"18","key":"2464_CR76","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.1021\/es101688h","volume":"44","author":"L Weijs","year":"2010","unstructured":"Weijs L, Yang RS, Covaci A, Das K, Blust R (2010) Physiologically based pharmacokinetic (PBPK) models for lifetime exposure to PCB 153 in male and female harbor porpoises (Phocoena phocoena): model development and evaluation. Environ Sci Technol 44(18):7023\u20137030","journal-title":"Environ Sci Technol"},{"key":"2464_CR77","unstructured":"WHO (2010) Characterization and application of physiologically based pharmacokinetic models in risk assessment. World Health Organization, International Programme on Chemical Safety (WHO\/IPCS), Geneva, Switzerland. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/44495\/9789241500906_eng.pdf . Accessed 22 Apr 2019"},{"issue":"3","key":"2464_CR78","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/psp4.21","volume":"4","author":"J Wojciechowski","year":"2015","unstructured":"Wojciechowski J, Hopkins AM, Upton RN (2015) Interactive pharmacometric applications using r and the shiny package. CPT Pharmacomet Syst Pharmacol 4(3):146\u2013159","journal-title":"CPT Pharmacomet Syst Pharmacol"},{"issue":"3","key":"2464_CR79","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1365-2885.2012.01420.x","volume":"36","author":"H Wu","year":"2013","unstructured":"Wu H, Baynes RE, Leavens T, Tell LA, Riviere JE (2013) Use of population pharmacokinetic modeling and Monte Carlo simulation to capture individual animal variability in the prediction of flunixin withdrawal times in cattle. J Vet Pharmacol Ther 36(3):248\u2013257","journal-title":"J Vet Pharmacol Ther"},{"issue":"1","key":"2464_CR80","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1080\/19440049.2011.624126","volume":"29","author":"F Yang","year":"2012","unstructured":"Yang F, Liu HW, Li M, Ding HZ, Huang XH, Zeng ZL (2012) Use of a Monte Carlo analysis within a physiologically based pharmacokinetic model to predict doxycycline residue withdrawal time in edible tissues in swine. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 29(1):73\u201384","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"issue":"3","key":"2464_CR81","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.taap.2015.10.016","volume":"289","author":"X Yang","year":"2015","unstructured":"Yang X, Doerge DR, Teeguarden JG, Fisher JW (2015) Development of a physiologically based pharmacokinetic model for assessment of human exposure to bisphenol A. Toxicol Appl Pharmacol 289(3):442\u2013456","journal-title":"Toxicol Appl Pharmacol"},{"issue":"10","key":"2464_CR82","doi-asserted-by":"publisher","first-page":"e0164641","DOI":"10.1371\/journal.pone.0164641","volume":"11","author":"X Yang","year":"2016","unstructured":"Yang X, Duan J, Fisher J (2016) Application of physiologically based absorption modeling to characterize the pharmacokinetic profiles of oral extended release methylphenidate products in adults. PLoS One 11(10):e0164641","journal-title":"PLoS One"},{"issue":"1","key":"2464_CR83","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/toxsci\/kfp198","volume":"112","author":"M Yoon","year":"2009","unstructured":"Yoon M, Nong A, Clewell HJ 3rd, Taylor MD, Dorman DC, Andersen ME (2009) Evaluating placental transfer and tissue concentrations of manganese in the pregnant rat and fetuses after inhalation exposures with a PBPK model. Toxicol Sci 112(1):44\u201358","journal-title":"Toxicol Sci"},{"issue":"11","key":"2464_CR84","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S1671-2927(07)60189-8","volume":"6","author":"Z Yu","year":"2007","unstructured":"Yu Z, Jiang C, Guo Y, Hu Y, Chen D (2007) Pharmacokinetics of flunixin meglumine after intravenous and intramuscular administration in pigs. Agric Sci China 6(11):1396\u20131401","journal-title":"Agric Sci China"},{"issue":"28","key":"2464_CR85","doi-asserted-by":"publisher","first-page":"5768","DOI":"10.1021\/acs.jafc.7b01740","volume":"65","author":"D Zeng","year":"2017","unstructured":"Zeng D, Lin Z, Fang B, Li M, Gehring R, Riviere JE, Zeng Z (2017) Pharmacokinetics of mequindox and its marker residue 1, 4-bisdesoxymequindox in swine following multiple oral gavage and intramuscular administration: an experimental study coupled with population physiologically based pharmacokinetic modeling. J Agric Food Chem 65(28):5768\u20135777","journal-title":"J Agric Food Chem"},{"issue":"1","key":"2464_CR86","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s13318-016-0329-2","volume":"42","author":"TJ Zurlinden","year":"2017","unstructured":"Zurlinden TJ, Reisfeld B (2017) Characterizing the effects of race\/ethnicity on acetaminophen pharmacokinetics using physiologically based pharmacokinetic modeling. Eur J Drug Metab Pharmacokinet 42(1):143\u2013153","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-019-02464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-019-02464-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-019-02464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T08:37:12Z","timestamp":1721205432000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-019-02464-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,25]]},"references-count":86,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2464"],"URL":"https:\/\/doi.org\/10.1007\/s00204-019-02464-z","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,25]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}